Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $29,017 | 1,516 | 99.3% |
| Education | $149.16 | 32 | 0.5% |
| Gift | $63.15 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $5,139 | 235 | $0 (2024) |
| PFIZER INC. | $3,927 | 300 | $0 (2024) |
| Amgen Inc. | $2,904 | 127 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $2,726 | 82 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,273 | 117 | $0 (2024) |
| Janssen Biotech, Inc. | $1,628 | 102 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $1,352 | 81 | $0 (2019) |
| Celgene Corporation | $1,258 | 74 | $0 (2019) |
| UCB, Inc. | $1,187 | 72 | $0 (2022) |
| GlaxoSmithKline, LLC. | $1,130 | 65 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,402 | 74 | Mallinckrodt Hospital Products Inc. ($259.45) |
| 2023 | $2,691 | 117 | Mallinckrodt Hospital Products Inc. ($478.57) |
| 2022 | $4,327 | 205 | ABBVIE INC. ($861.09) |
| 2021 | $3,785 | 182 | Mallinckrodt Hospital Products Inc. ($839.90) |
| 2020 | $3,925 | 214 | AbbVie Inc. ($758.90) |
| 2019 | $4,842 | 296 | AbbVie, Inc. ($874.92) |
| 2018 | $4,688 | 255 | Novartis Pharmaceuticals Corporation ($516.99) |
| 2017 | $3,569 | 206 | AbbVie, Inc. ($728.21) |
All Payment Transactions
1,549 individual payment records from CMS Open Payments — Page 2 of 62
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/15/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: IMMUNOLOGY | ||||||
| 07/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: PSYCHIATRY | ||||||
| 07/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: IMMUNOLOGY | ||||||
| 07/08/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $10.45 | General |
| Category: Dermatology | ||||||
| 07/03/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological), NUCALA | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: IMMUNOLOGY | ||||||
| 07/01/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: Dermatology | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 06/19/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Rare Disease | ||||||
| 06/17/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: IMMUNOLOGY | ||||||
| 06/14/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $34.13 | General |
| Category: Immunology | ||||||
| 06/10/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: IMMUNOLOGY | ||||||
| 06/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Immunology | ||||||
| 06/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Dermatology | ||||||
| 05/21/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $8.59 | General |
| Category: IMMUNOLOGY | ||||||
| 05/06/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: IMMUNOLOGY | ||||||
| 04/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.54 | General |
| Category: IMMUNOLOGY | ||||||
| 04/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Diabetes | ||||||
| 04/17/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 04/11/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Inflammation | ||||||
| 04/09/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Rare Disease | ||||||
| 04/01/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 03/29/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: IMMUNOLOGY | ||||||
| 03/29/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Inflammation and Autoimmunity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 75 | 77 | $10,146 | $3,032 |
| 2022 | 12 | 547 | 33,916 | $3.6M | $729,856 |
| 2021 | 13 | 571 | 33,756 | $4.6M | $933,366 |
| 2020 | 16 | 710 | 32,055 | $4.8M | $1.0M |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 77 | $10,146 | $3,032 | 29.9% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 23 | 13,075 | $1.7M | $450,881 | 26.5% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2022 | 24 | 19,350 | $1.6M | $208,141 | 12.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 279 | 536 | $69,680 | $33,431 | 48.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 47 | 294 | $61,740 | $15,657 | 25.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 24 | 115 | $69,000 | $11,782 | 17.1% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2022 | 17 | 120 | $15,600 | $2,699 | 17.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $5,925 | $2,611 | 44.1% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 26 | 155 | $10,540 | $1,913 | 18.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 23 | 31 | $7,200 | $1,432 | 19.9% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2022 | 26 | 134 | $2,680 | $601.32 | 22.4% |
| 20551 | Injection into tendon at attachment to bone or muscle | Office | 2022 | 13 | 17 | $3,230 | $392.07 | 12.1% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 30 | 74 | $740.00 | $314.64 | 42.5% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2021 | 21 | 11,900 | $1.5M | $471,349 | 30.5% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2021 | 15 | 6,570 | $1.6M | $208,201 | 12.9% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2021 | 15 | 13,750 | $1.2M | $181,480 | 15.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 290 | 546 | $71,000 | $33,746 | 47.5% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 28 | 139 | $83,400 | $15,859 | 19.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 36 | 249 | $52,290 | $14,210 | 27.2% |
| 96415 | Infusion of chemotherapy into a vein | Office | 2021 | 22 | 155 | $20,150 | $3,764 | 18.7% |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2021 | 27 | 140 | $9,520 | $1,848 | 19.4% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 25 | 36 | $8,775 | $1,364 | 15.5% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2021 | 26 | 122 | $2,440 | $534.82 | 21.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2021 | 42 | 116 | $1,175 | $434.77 | 37.0% |
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2021 | 12 | 15 | $3,225 | $296.42 | 9.2% |
About Dr. Sandra Hoffmann, M.D
Dr. Sandra Hoffmann, M.D is a Rheumatology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477565893.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandra Hoffmann, M.D has received a total of $29,229 in payments from pharmaceutical and medical device companies, with $1,402 received in 2024. These payments were reported across 1,549 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($29,017).
As a Medicare-enrolled provider, Hoffmann has provided services to 1,903 Medicare beneficiaries, totaling 99,804 services with total Medicare billing of $2.7M. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Saint Louis, MO
- Active Since 08/13/2006
- Last Updated 09/29/2023
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1477565893
Products in Payments
- ACTHAR (Biological) $4,078
- XELJANZ (Drug) $3,740
- Enbrel (Biological) $1,912
- COSENTYX (Biological) $1,770
- RINVOQ (Biological) $1,462
- Humira (Biological) $1,365
- Cimzia (Drug) $1,187
- BENLYSTA (Biological) $1,005
- ORENCIA (Biological) $914.88
- Otezla (Drug) $822.44
- TALTZ (Drug) $664.80
- TREMFYA (Drug) $638.13
- RINVOQ (Drug) $491.21
- KEVZARA (Drug) $479.20
- SIMPONI ARIA (Biological) $445.37
- Rinvoq (Biological) $441.62
- REMICADE (Biological) $391.34
- SAPHNELO (Biological) $368.41
- STELARA (Biological) $360.95
- HUMIRA (Biological) $349.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Saint Louis
Dr. Alfred Kim, Md, MD
Rheumatology — Payments: $402,454
Dr. Sona Kamat, M.d, M.D
Rheumatology — Payments: $266,392
Dr. Adam Kilian, M.d, M.D
Rheumatology — Payments: $259,162
Dr. Benjamin Schwartz, Md, MD
Rheumatology — Payments: $145,337
Akgun Ince, M.d, M.D
Rheumatology — Payments: $55,223
Dr. John Budd, Md, MD
Rheumatology — Payments: $27,292